| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Mar 19, 2025 | Mar 21, 2025 | Biotech Growth N V 10% | Sell | $2.07 | $12M | -67.91% |
| Aug 28, 2024 | Aug 30, 2024 | Versant Venture Capital Vi, L.P. 10% | Sell | $6.32 | $1M | -3.45% |
| Oct 17, 2023 | Oct 19, 2023 | Biotech Growth N V 10% | Buy | $2.34 | $934,080 | +4.49% |
| Jul 05, 2023 | Jul 07, 2023 | Ra Capital Management, L.P. Dir | Buy | $5 | $5M | +20.98% |
| Jul 05, 2023 | Jul 06, 2023 | Behbahani Ali Dir | Buy | $5 | $5M | +18.22% |
| Jun 30, 2023 | Jul 03, 2023 | Biotech Growth N V 10% | Buy | $5 | $5M | +10.97% |
| Jun 27, 2023 | Jun 29, 2023 | Biotech Growth N V 10% | Buy | $5.49 | $10M | +19.64% |
| Jun 27, 2023 | Jun 28, 2023 | Epstein David M. | Sell | $6.7 | $167,500 | -2.60% |
| Dec 21, 2022 | Dec 23, 2022 | Ni Fang | Buy | $1.28 | $72,366 | +31.01% |
| Oct 31, 2022 | Nov 02, 2022 | Biotech Growth N V 10% | Buy | $2.25 | $224,912 | +1.82% |
| Oct 27, 2022 | Oct 31, 2022 | Biotech Growth N V 10% | Buy | $2.02 | $736,186 | +6.46% |
| Oct 21, 2022 | Oct 25, 2022 | Biotech Growth N V 10% | Buy | $1.51 | $132,750 | +1.76% |
| Oct 19, 2022 | Oct 21, 2022 | Biotech Growth N V 10% | Buy | $1.36 | $179,120 | +2.65% |
| Jun 29, 2022 | Jun 30, 2022 | Ni Fang | Buy | $2.44 | $61,018 | +26.59% |
| Apr 27, 2022 | Apr 29, 2022 | Biotech Growth N V 10% | Buy | $2.61 | $1M | +7.96% |
| Apr 18, 2022 | Apr 20, 2022 | Biotech Growth N V 10% | Buy | $3.27 | $980,580 | +6.54% |
| Apr 12, 2022 | Apr 14, 2022 | Biotech Growth N V 10% | Buy | $3.48 | $879,817 | +5.96% |
| May 12, 2021 | May 13, 2021 | Hatzis-Schoch Brent | Sell | $27.42 | $111,805 | -32.68% |
| May 03, 2021 | May 05, 2021 | Roberts Christopher D. Chief Scientific Officer | Sell | $26.64 | $66,602 | -43.86% |
| Apr 12, 2021 | Apr 14, 2021 | Hatzis-Schoch Brent | Sell | $25 | $101,950 | -32.68% |
| Apr 05, 2021 | Apr 07, 2021 | Roberts Christopher D. Chief Scientific Officer | Sell | $25.54 | $63,848 | -43.86% |
| Mar 12, 2021 | Mar 16, 2021 | Hatzis-Schoch Brent | Sell | $26.36 | $107,493 | -32.68% |
| Mar 03, 2021 | Mar 04, 2021 | Roberts Christopher D. Chief Scientific Officer | Sell | $26.1 | $65,262 | -43.86% |
| Feb 12, 2021 | Feb 13, 2021 | Hatzis-Schoch Brent | Sell | $27.23 | $111,025 | -32.68% |
| Feb 03, 2021 | Feb 04, 2021 | Roberts Christopher D. Chief Scientific Officer | Sell | $25.35 | $63,375 | -43.86% |
| Jan 12, 2021 | Jan 15, 2021 | Hatzis-Schoch Brent | Sell | $34.03 | $394,041 | -57.95% |
| Jan 08, 2021 | Jan 11, 2021 | Leggett Thomas CFO | Sell | $33.94 | $101,820 | -0 |
| Jan 04, 2021 | Jan 06, 2021 | Roberts Christopher D. Chief Scientific Officer | Sell | $31.41 | $78,525 | -43.86% |
| Jan 04, 2021 | Jan 06, 2021 | Epstein David M. | Sell | $31.13 | $373,505 | -1.23% |
| Dec 14, 2020 | Dec 17, 2020 | Hatzis-Schoch Brent | Sell | $34.95 | $142,522 | -57.62% |